Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 176

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Thrombolytic therapy of pulmonary embolism

Open access
Thabut, Gabriel, Thabut, Dominique, Myers, Robert P, Bernard-Chabert, Brigitte, Marrash-Chahla, Rolana, Mal, Hervé, Fournier, Michel · 2002 · Journal of the American College of Cardiology

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0735-1097(02)02381-1

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Research works printed but not linked: 37

  1. Arcasoy, 1999, Thrombolytic therapy of pulmonary embolism, Chest, 115, 1695, 10.1378/chest.115.6.1695 · DOI · Paper page
  2. Goldhaber, 1998, Pulmonary embolism, N Engl J Med, 339, 93, 10.1056/NEJM199807093390207 · DOI · Paper page
  3. Barritt, 1960, Anticoagulants drugs in the treatment of pulmonary embolism, Lancet, 1, 1309, 10.1016/S0140-6736(60)92299-6 · DOI · Paper page
  4. Kasper, 1997, Management strategies and determinants of outcome in acute major pulmonary embolism, J Am Coll Cardiol, 30, 1165, 10.1016/S0735-1097(97)00319-7 · DOI · Paper page
  5. Goldhaber, 1999, Acute pulmonary embolism, Lancet, 353, 1386, 10.1016/S0140-6736(98)07534-5 · DOI · Paper page
  6. Ly, 1978, A controlled clinical trial of streptokinase and heparin in the treatment of major pulmonary embolism, Acta Med Scand, 203, 465, 10.1111/j.0954-6820.1978.tb14909.x · DOI · Paper page
  7. Marini, 1988, Fibrinolytic effects of urokinase and heparin in acute pulmonary embolism, Respiration, 54, 162, 10.1159/000195517 · DOI
  8. Levine, 1990, A randomized trial of a single bolus dosage regimen of recombinant tissue plasminogen activator in patients with acute pulmonary embolism, Chest, 98, 1473, 10.1378/chest.98.6.1473 · DOI · Paper page
  9. Goldhaber, 1993, Alteplase versus heparin in acute pulmonary embolism, Lancet, 341, 507, 10.1016/0140-6736(93)90274-K · DOI · Paper page
  10. Dalla-Volta, 1992, PAIMS 2, J Am Coll Cardiol, 20, 520, 10.1016/0735-1097(92)90002-5 · DOI · Paper page
  11. Tibbutt, 1974, Comparison by controlled clinical trial of streptokinase and heparin in treatment of life-threatening pulmonary embolism, Br Med J, 1, 343, 10.1136/bmj.1.5904.343 · DOI · Paper page
  12. 1990, Tissue plasminogen activator for the treatment of acute pulmonary embolism, Chest, 97, 528, 10.1378/chest.97.3.528 · DOI · Paper page
  13. Kasper, 1997, Prognostic significance of right ventricular afterload stress detected by echocardiography in patients with clinically suspected pulmonary embolism, Heart, 77, 346, 10.1136/hrt.77.4.346 · doi:10.1136/hrt.77.4.346
  14. Cannon, 1996, Cardiovascular risk stratification of pulmonary embolism, Am J Cardiol, 78, 1149, 10.1016/S0002-9149(96)90069-7 · doi:10.1016/s0002-9149(96)90069-7
  15. Goldhaber, 1997, Pulmonary embolism thrombolysis, Circulation, 96, 716, 10.1161/01.CIR.96.3.716 · doi:10.1161/01.cir.96.3.716
  16. Goldhaber, 1995, Contemporary pulmonary embolism thrombolysis, Chest, 107, 45S, 10.1378/chest.107.1_Supplement.45S · DOI
  17. Konstantinides, 1999, Submassive and massive pulmonary embolism, Thromb Haemost, 82, 104
  18. Konstantinides, 1997, Association between thrombolytic treatment and the prognosis of hemodynamically stable patients with major pulmonary embolism, Circulation, 96, 882, 10.1161/01.CIR.96.3.882 · DOI · Paper page
  19. Dalen, 1997, Thrombolytic therapy for pulmonary embolism, Arch Intern Med, 157, 2550, 10.1001/archinte.1997.00440430026003 · doi:10.1001/archinte.1997.00440430026003
  20. Jadad, 1996, Assessing the quality of reports of randomized clinical trials, Control Clin Trials, 17, 1, 10.1016/0197-2456(95)00134-4 · DOI · Paper page
  21. Demets, 1987, Methods for combining randomized clinical trials, Stat Med, 6, 341, 10.1002/sim.4780060325 · DOI · Paper page
  22. Egger, 1997, Bias in meta-analysis detected by a simple, graphical test, BMJ, 315, 629, 10.1136/bmj.315.7109.629 · DOI · Paper page
  23. Jerjes-Sanchez, 1995, Streptokinase and heparin versus heparin alone in massive pulmonary embolism, J Thromb Thrombolysis, 2, 227, 10.1007/BF01062714 · DOI · Paper page
  24. Carson, 1992, The clinical course of pulmonary embolism, N Engl J Med, 326, 1240, 10.1056/NEJM199205073261902 · DOI · Paper page
  25. Goldhaber, 2001, Thrombolysis in pulmonary embolism, Thromb Haemost, 86, 444, 10.1055/s-0037-1616242 · doi:10.1055/s-0037-1616242
  26. Goldhaber, 1992, Pulmonary embolism thrombolysis, J Am Coll Cardiol, 19, 246, 10.1016/0735-1097(92)90473-Z · doi:10.1016/0735-1097(92)90473-z
  27. Goldhaber, 2001, Thrombolysis in pulmonary embolism, Circulation, 104, 2876, 10.1161/circ.104.24.2876 · doi:10.1161/circ.104.24.2876
  28. Hamel, 2001, Thrombolysis or heparin therapy in massive pulmonary embolism with right ventricular dilation, Chest, 120, 120, 10.1378/chest.120.1.120 · doi:10.1378/chest.120.1.120
  29. Konstantinides, 2002, Alteplase improves the clinical course of patients with major pulmonary embolism, J Am Coll Cardiol, 39, 272A, 10.1016/S0735-1097(02)81221-9 · doi:10.1016/s0735-1097(02)81221-9
  30. Kanter, 1997, Thrombolytic therapy for pulmonary embolism, Chest, 111, 1241, 10.1378/chest.111.5.1241 · DOI · Paper page
  31. Mikkola, 1997, Increasing age is a major risk factor for hemorrhagic complications after pulmonary embolism thrombolysis, Am Heart J, 134, 69, 10.1016/S0002-8703(97)70108-X · DOI
  32. Goldhaber, 1992, Recombinant tissue-type plasminogen activator versus a novel dosing regimen of urokinase in acute pulmonary embolism, J Am Coll Cardiol, 20, 24, 10.1016/0735-1097(92)90132-7 · DOI · Paper page
  33. Meneveau, 1998, Comparative efficacy of a two-hour regimen of streptokinase versus alteplase in acute massive pulmonary embolism, J Am Coll Cardiol, 31, 1057, 10.1016/S0735-1097(98)00068-0 · DOI · Paper page
  34. LeLorier, 1997, Discrepancies between meta-analyses and subsequent large randomized, controlled trials, N Engl J Med, 337, 536, 10.1056/NEJM199708213370806 · DOI · Paper page
  35. Pogue, 1998, Overcoming the limitations of current meta-analysis of randomised controlled trials, Lancet, 351, 47, 10.1016/S0140-6736(97)08461-4 · DOI · Paper page
  36. Flather, 1997, Strengths and limitations of meta-analysis, Control Clin Trials, 18, 568, 10.1016/S0197-2456(97)00024-X · DOI · Paper page
  37. Lambert, 2002, A comparison of summary patient-level covariates in meta-regression with individual patient data meta-analysis, J Clin Epidemiol, 55, 86, 10.1016/S0895-4356(01)00414-0 · DOI · Paper page

Cited by

See all 176

Metadata

Authors
Thabut, G., Thabut, D., Myers, R. P., Bernard-Chabert, B., Marrash-Chahla, R., Mal, H., & Fournier, M.
Venue
Journal of the American College of Cardiology
Publisher
Elsevier BV
Published
2002-11
Volume
40
Issue
9
Pages
1660-1667
ISSN
0735-1097 (ISSN-L)
OpenAlex
W2100964332
Cited by
176
References
4
FWCI
6.61
Type
journal article
Language
en
Open access
bronze
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Thrombolytic therapy of pulmonary embolism. https://app.cochat.ai/papers/10.1016/s0735-1097(02)02381-1
The paper
Thabut, G., Thabut, D., Myers, R. P., Bernard-Chabert, B., Marrash-Chahla, R., Mal, H., & Fournier, M. (2002). Thrombolytic therapy of pulmonary embolism. Journal of the American College of Cardiology. https://doi.org/10.1016/s0735-1097(02)02381-1

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.